These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17933688)

  • 1. Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulators.
    Kremoser C; Albers M; Burris TP; Deuschle U; Koegl M
    Drug Discov Today; 2007 Oct; 12(19-20):860-9. PubMed ID: 17933688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear receptor drug discovery.
    Chen T
    Curr Opin Chem Biol; 2008 Aug; 12(4):418-26. PubMed ID: 18662801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profiling.
    Pearce KH; Iannone MA; Simmons CA; Gray JG
    Drug Discov Today; 2004 Sep; 9(17):741-51. PubMed ID: 15450240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles for modulation of the nuclear receptor superfamily.
    Gronemeyer H; Gustafsson JA; Laudet V
    Nat Rev Drug Discov; 2004 Nov; 3(11):950-64. PubMed ID: 15520817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The flip side: Identifying small molecule regulators of nuclear receptors.
    Schulman IG; Heyman RA
    Chem Biol; 2004 May; 11(5):639-46. PubMed ID: 15157874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of selective nuclear receptor modulator-induced conformational changes in the nuclear receptor to allow interaction with coactivator and corepressor proteins in living cells.
    Awais M; Sato M; Umezawa Y
    Chembiochem; 2007 May; 8(7):737-43. PubMed ID: 17387660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of assays for nuclear receptor modulators using fluorescently tagged proteins.
    Martinez ED; Hager GL
    Methods Enzymol; 2006; 414():37-50. PubMed ID: 17110185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma.
    Chao EY; Collins JL; Gaillard S; Miller AB; Wang L; Orband-Miller LA; Nolte RT; McDonnell DP; Willson TM; Zuercher WJ
    Bioorg Med Chem Lett; 2006 Feb; 16(4):821-4. PubMed ID: 16307879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha.
    Busch BB; Stevens WC; Martin R; Ordentlich P; Zhou S; Sapp DW; Horlick RA; Mohan R
    J Med Chem; 2004 Nov; 47(23):5593-6. PubMed ID: 15509154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.
    Vijayan RS; Ghoshal N
    J Mol Graph Model; 2008 Oct; 27(3):286-98. PubMed ID: 18565775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of nuclear receptor interacting proteins using yeast two-hybrid technology. Applications to drug discovery.
    Nagpal S; Ghosn CR; Chandraratna RA
    Methods Mol Biol; 2001; 176():359-76. PubMed ID: 11554336
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
    Burendahl S; Treuter E; Nilsson L
    Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity.
    Salum LB; Polikarpov I; Andricopulo AD
    J Chem Inf Model; 2008 Nov; 48(11):2243-53. PubMed ID: 18937440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel progesterone receptor modulators with gene selective and context-dependent partial agonism.
    Berrodin TJ; Jelinsky SA; Graciani N; Butera JA; Zhang Z; Nagpal S; Winneker RC; Yudt MR
    Biochem Pharmacol; 2009 Jan; 77(2):204-15. PubMed ID: 19013437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of nomenclature of nuclear receptors.
    Germain P; Staels B; Dacquet C; Spedding M; Laudet V
    Pharmacol Rev; 2006 Dec; 58(4):685-704. PubMed ID: 17132848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncanonical mechanisms to regulate nuclear receptor signaling.
    Sadana P
    Future Med Chem; 2012 Jun; 4(10):1307-33. PubMed ID: 22800372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear receptors and their selective pharmacologic modulators.
    Burris TP; Solt LA; Wang Y; Crumbley C; Banerjee S; Griffett K; Lundasen T; Hughes T; Kojetin DJ
    Pharmacol Rev; 2013 Apr; 65(2):710-78. PubMed ID: 23457206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMILE, a new orphan nuclear receptor SHP-interacting protein, regulates SHP-repressed estrogen receptor transactivation.
    Xie YB; Lee OH; Nedumaran B; Seong HA; Lee KM; Ha H; Lee IK; Yun Y; Choi HS
    Biochem J; 2008 Dec; 416(3):463-73. PubMed ID: 18657049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.